Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05112237 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Study acronym: MyCLIMB
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Site details revised at 29 of 29 sites
    v18
  2. Re-verified, no change to tracked fieldsv17
  3. Study sites: 28 to 29v16
  4. Study sites: 27 to 28v15
  5. Study sites: 24 to 27v14
Show 12 earlier versionsHide 12 earlier versions
  1. Study sites: 21 to 24v13
  2. Study sites: 19 to 21v12
  3. Study sites: 18 to 19v11
  4. Study sites: 12 to 18v10
  5. Study sites: 11 to 12
    • Eligibility criteria expanded, about 27 words
    v9
  6. Study sites: 8 to 11v8
  7. Study sites: 7 to 8v7
  8. Study sites: 5 to 7v6
  9. Study sites: 3 to 5v5
  10. Study sites: 2 to 3v4
  11. Study sites: 1 to 2v3
  12. Start date changed from estimate of Nov 2021 to Nov 1, 2021
    • Site contact updated
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to collect information on patients with cardiomyopathy (CM) due to mutations in the MYBPC3 gene, to evaluate their disease course, burden of illness, risk factors for this disease, and the quality of life (QoL). This study will also collect information on treatments, procedures and outcome in infants and children up to 18 yrs who have this mutation.
Trial Details
NCT Number NCT05112237
Lead Sponsor Tenaya Therapeutics
Conditions
(from sponsor)		 Cardiomyopathy
Related terms Cardiomyopathies, Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Restrictive
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov